AI-Powered ultrasound could bring heart testing to geriatric wards

NCT ID NCT07701369

First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time

Summary

This study investigates whether a portable, AI-assisted ultrasound device can accurately measure heart function in patients aged 75 and older hospitalized with heart failure. Geriatricians, after a one-day training, use the AI tool to assess the heart's pumping ability, and results are compared to standard echocardiography performed by a cardiologist. If proven reliable, this technology could make heart assessments more accessible in geriatric settings, where specialist access is often limited.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
AI-assisted echocardiography using a handheld ultrasound device and automated analysis software
What this could lead to
If successful, this approach could make heart function assessment more accessible for elderly patients in geriatric wards, reducing the need for specialist cardiologist referrals.
What could go wrong
This is a relatively small, single-center study. The AI tool may not be as accurate as standard echocardiography, and results may not apply to all older patients or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Broca Hospital

    Paris, 75013, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.